Federica Federici

Dr. Federica Federici

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2007 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
STS. Turroni
S. Turroni
BVB. Vitali
B. Vitali
CBC. Bendazzoli
C. Bendazzoli
MCM. Candela
M. Candela
RGRoberto Gotti
Roberto Gotti
PBP. Brigidi
P. Brigidi
Aims: This study was undertaken to evaluate the oxalate-degrading activity in several Lactobacillus species widely used in probiotic dairy and pharmaceutical preparations. Functional characterization of oxalyl-CoA decarboxylase and formyl-CoA transferase in Lactobacillus acidophilus was performed in order to assess the possible contribution of Lactobacillus in regulating the intestinal oxalate homeostasis. Methods and Results: In order to determine the oxalate-degrading ability in 60 Lactobacillus strains belonging to 12 species, a screening was carried out by using an enzymatic assay. A high variability in the oxalate-degrading capacity was found in the different species. Strains of Lact. acidophilus and Lactobacillus gasseri showed the highest oxalate-degrading activity. Oxalyl-CoA decarboxylase and formyl-CoA transferase genes from Lact. acidophilus LA14 were cloned and sequenced. The activity of the recombinant enzymes was assessed by capillary electrophoresis. Conclusions: Strains of Lactobacillus with a high oxalate-degrading activity were identified. The function and significance of Lact. acidophilus LA14 oxalyl-CoA decarboxylase and formyl-CoA transferase in oxalate catabolism were demonstrated. These results suggest the potential use of Lactobacillus strains for the degradation of oxalate in the human gut. Significance and Impact of the Study: Identification of probiotic strains with oxalate-degrading activity can offer the opportunity to provide this capacity to individuals suffering from an increased body burden of oxalate and oxalate-associated disorders.

1 September 2007 in JACC
Verified
Journal Article
Closed access
Gianluca CampoGianluca Campo
Gianluca Campo
MVMarco Valgimigli
Marco Valgimigli
Donato GemmatiDonato Gemmati
Donato Gemmati
GPGianfranco Percoco
Gianfranco Percoco
LCLinda Catozzi
Linda Catozzi
RFRoberto Ferrari
Roberto Ferrari

1 September 2004 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
FFFederica Federici
Federica Federici
BVBeatrice Vitali
Beatrice Vitali
RGRoberto Gotti
Roberto Gotti
MPMaria Rosalia Pasca
Maria Rosalia Pasca
SGSilvia Gobbi
Silvia Gobbi
PBPatrizia Brigidi
Patrizia Brigidi
Oxalyl coenzyme A (CoA) decarboxylase (Oxc) is a key enzyme in the catabolism of the highly toxic compound oxalate, catalyzing the decarboxylation of oxalyl-CoA to formyl-CoA. The gene encoding a novel oxalyl-CoA decarboxylase from Bifidobacterium lactis DSM 10140 (oxc) was identified and characterized. This strain, isolated from yogurt, showed the highest oxalate-degrading activity in a preliminary screening with 12 strains belonging to Bifidobacterium, an anaerobic intestinal bacterial group largely used in probiotic products. The oxc gene was isolated by probing a B. lactis genomic library with a probe obtained by amplification of the oxalyl-CoA decarboxylase gene from Oxalobacter formigenes, an anaerobic bacterium of the human intestinal microflora. The oxc DNA sequence analysis revealed an open reading frame of 1,773 bp encoding a deduced 590-amino-acid protein with a molecular mass of about 63 kDa. Analysis of amino acid sequence showed a significant homology (47%) with oxalyl-CoA decarboxylase of O. formigenes and a typical thiamine pyrophosphate-binding site that has been reported for several decarboxylase enzymes. Primer extension experiments with oxc performed by using RNA isolated from B. lactis identified the transcriptional start site 28 bp upstream of the ATG start codon, immediately adjacent to a presumed promoter region. The protein overexpressed in Escherichia coli cross-reacted with an anti-O. formigenes oxalyl-CoA decarboxylase antibody. Enzymatic activity, when evaluated by capillary electrophoresis analysis, demonstrated that the consumption substrate oxalyl-CoA was regulated by a product inhibition of the enzyme. These findings suggest a potential role for Bifidobacterium in the intestinal degradation of oxalate.

23 February 2004 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
MMM. Massi
M. Massi
BVB. Vitali
B. Vitali
FFFederica Federici
Federica Federici
DMD. Matteuzzi
D. Matteuzzi
PBP. Brigidi
P. Brigidi
Aims: A molecular methodology based on PCR‐associated automated ribotyping was developed to specifically detect the Lactobacillus strains of two probiotic products (an orally administered lyophilized preparation and vaginal tablets) in human faeces and vaginal swabs. Methods and Results: The 16S‐23S rDNA sequences and the ribotype profiles of the probiotic lactobacilli were characterized and new species‐specific primer sets were designed. The identification of faecal and vaginal lactobacilli isolated from subjects administered with the probiotic products was performed by using PCR with species‐specific primers followed by strain‐specific automated ribotyping. Conclusions: The PCR‐ribotyping identification allowed to study the colonization patterns of the probiotic lactobacilli in the human gut and vagina evidencing the strains with the best survival capability. Significance and Impact of the Study: The proposed molecular method represents a powerful tool of strain‐specific identification, useful for differentiating exogenous from indigenous strains in any microbial ecosystem and for rationally choosing probiotic bacteria with the best chance of survival in the host.

21 November 2017 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
PPP. Pidutti
P. Pidutti
FFFederica Federici
Federica Federici
JBJessica Brandi
Jessica Brandi
LML. Manna
L. Manna
ERE. Rizzi
E. Rizzi
DCDaniela Cecconi
Daniela Cecconi
Aims The aim of this study was to investigate the antimicrobial potential of proteins secreted by a new strain of Lactobacillus salivarius. Methods and Results The secretome of L. salivarius SGL 03 strain was analysed by gel-assisted fractionation and MS/MS to identify low-molecular-mass proteins. This strategy allowed us to identify 10 secreted proteins. Then, a combination of heterologous expression and agar well diffusion was used to characterize them as to their antimicrobial activity, mechanisms of action and stability. Our findings indicate that L27 and L30 proteins of the 50S ribosomal subunit have antimicrobial activity against Streptococcus pyogenes, Streptococcus uberis and Enterococcus faecium. In addition, both proteins are bactericidal against S. pyogenes and maintain their antimicrobial activity after different protease treatments, at acidic pH, after heat treatment, and if stored in a refrigerated ambient at least at 4°C. Conclusions The overall results demonstrated that the L27 and L30 ribosomal proteins are of interest as new antimicrobial molecules to prevent the growth of S. pyogenes, S. uberis and E. faecium. Significance and Impact of the Study Our results provide the first insight into the extra-ribosomal activity of L27 and L30 secreted proteins of L. salivarius. This study demonstrated the capacity of L. salivarius SGL 03 to produce antimicrobial molecules and suggested this strain as a promising probiotic candidate.

1 December 2009 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
Donato GemmatiDonato Gemmati
Donato Gemmati
FFFederica Federici
Federica Federici
LCLinda Catozzi
Linda Catozzi
SGSergio Gianesini
Sergio Gianesini
GTGiovanna Tacconi
Giovanna Tacconi
PZPaolo Zamboni
Paolo Zamboni